Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             43 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Application of 3-D Printed Kidney Model in Partial Nephrectomy for Predicting Surgical Outcomes: A Feasibility Study Kyung, Yoon Soo

17 5 p. e878-e884
artikel
2 A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC) Shah, Ruchitbhai

17 5 p. 356-365.e1
artikel
3 Association of Low Socioeconomic Status With Adverse Prostate Cancer Pathology Among African American Men Who Underwent Radical Prostatectomy Weprin, Samuel A.

17 5 p. e1054-e1059
artikel
4 Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis Barata, Pedro C.

17 5 p. 366-372
artikel
5 A 25-year Period Analysis of Other-cause Mortality in Localized Prostate Cancer Knipper, Sophie

17 5 p. 395-401
artikel
6 Bladder Perivascular Epithelioid Cell Tumor: Dynamic CT and MRI Presentation of 2 Cases With 2-year Follow-up and Review of the Literature Xuesong, Du

17 5 p. e916-e922
artikel
7 Chemotherapy Toxicity Confirms Diagnosis of Urachal Carcinoma Maslov, Diana V.

17 5 p. e913-e915
artikel
8 Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series Casuscelli, Jozefina

17 5 p. 373-379.e4
artikel
9 Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors Verbiest, Annelies

17 5 p. e981-e994
artikel
10 Clinical Efficacy and Complication Rate of Sunitinib 2/1 Versus 4/2 Schedule for the Treatment of Metastatic Renal Cell Cancer: A Systematic Review and Meta-Analysis Chen, Chenglong

17 5 p. 319-331
artikel
11 Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes Su, Shiqiang

17 5 p. e1048-e1053
artikel
12 Comparison of Open Versus Robotically Assisted Cytoreductive Radical Prostatectomy for Metastatic Prostate Cancer Preisser, Felix

17 5 p. e939-e945
artikel
13 Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors Palumbo, Carlotta

17 5 p. e1026-e1035
artikel
14 Defining End Points in Phase II Trials of Metastatic Castration-Resistant Prostate Cancer. Re: Impact of Addition of Metformin to Abiraterone in Metastatic Castration-Resistant Prostate Cancer Patients With Disease Progressing While Receiving Abiraterone Treatment (MetAb-Pro): Phase 2 Pilot Study O’Reilly, David

17 5 p. e886-e887
artikel
15 Disease Characteristics and Completion of Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223 in an International Early Access Program Saad, Fred

17 5 p. 348-355.e5
artikel
16 Editorial Board
17 5 p. A5
artikel
17 Efficacy and Safety of Carboplatin Plus Paclitaxel as the First-, Second-, and Third-line Chemotherapy in Men With Castration-resistant Prostate Cancer Fujiwara, Maki

17 5 p. e923-e929
artikel
18 Efficacy of Immediate Postoperative Instillation of Chemotherapy for Primary Non–Muscle-Invasive Bladder Cancer in Real-World Clinical Practice Murakami, Kaoru

17 5 p. e1003-e1010
artikel
19 Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant van Nuland, Merel

17 5 p. e893-e896
artikel
20 Folic Acid: A New Weapon for Mucositis? Alkan, Ali

17 5 p. e885
artikel
21 Genomic Analysis and Treatment Response of a Bladder Urothelial Carcinoma With Sarcomatoid Variant Histology Narayan, Vikram M.

17 5 p. e888-e892
artikel
22 High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy Hapakova, Nikola

17 5 p. e1020-e1025
artikel
23 Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation Beulque, Yana

17 5 p. e909-e912
artikel
24 Immunotherapy in Dialysis-Dependent Cancer Patients: Our Experience in Patients With Metastatic Renal Cell Carcinoma and a Review of the Literature Vitale, Maria Giuseppa

17 5 p. e903-e908
artikel
25 Japanese Case of Enzalutamide-Resistant Prostate Cancer Harboring a SPOP Mutation With Scattered Allelic Imbalance: Response to Platinum-Based Therapy Watanabe, Keitaro

17 5 p. e897-e902
artikel
26 Lymph Node Density as an Independent Prognostic Factor in Node-Positive Renal-Cell Carcinoma: Results From the Surveillance, Epidemiology, and End Results Program Liao, Xinyang

17 5 p. e968-e980
artikel
27 Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index De Nunzio, Cosimo

17 5 p. 402-407
artikel
28 New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes Di Nunno, Vincenzo

17 5 p. e871-e877
artikel
29 Periprostatic Fat Thickness on MRI is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Chinese Patients With Newly Diagnosed Prostate Cancer Treated With Androgen Deprivation Therapy Huang, Haichao

17 5 p. e1036-e1047
artikel
30 Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer Stangl-Kremser, Judith

17 5 p. 389-394
artikel
31 Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 Marandino, Laura

17 5 p. 332-347.e2
artikel
32 Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry Sung, John M.

17 5 p. e995-e1002
artikel
33 Radical Prostatectomy Sociodemographic Disparities Based on Hospital and Physician Volume Omidele, Olamide O.

17 5 p. e1011-e1019
artikel
34 Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study Schmidinger, Manuela

17 5 p. e957-e967
artikel
35 Reviewing the Demographic, Prognostic, and Treatment Factors of Primary Adenocarcinoma of the Bladder: A SEER Population-based Study Natale, Caleb

17 5 p. 380-388
artikel
36 Salvage Radiotherapy for Recurrent Prostate Cancer: Can the Prognostic Grade Group System Inform Treatment Timing? Tay, Kae Jack

17 5 p. e930-e938
artikel
37 Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands Westgeest, Hans M.

17 5 p. e946-e956
artikel
38 Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer Haque, Waqar

17 5 p. e1069-e1079
artikel
39 Table of Contents
17 5 p. A7-A13
artikel
40 The Alternative 2/1 Schedule of Sunitinib is Superior to the Traditional 4/2 Schedule in Patients With Metastatic Renal Cell Carcinoma: A Meta-analysis Sun, Yi

17 5 p. e847-e859
artikel
41 Transperineal Magnetic Resonance Imaging–Targeted Biopsy May Perform Better Than Transrectal Route in the Detection of Clinically Significant Prostate Cancer: Systematic Review and Meta-analysis Tu, Xiang

17 5 p. e860-e870
artikel
42 Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study Konishi, Sakae

17 5 p. e1080-e1089
artikel
43 Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer Tan, Wei Shen

17 5 p. e1060-e1068
artikel
                             43 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland